Physician
MCM Pediatric and Adolescent Home Practice, P.A.
MCM Pediatric and Adolescent Home Practice, P.A. was paid $10.11M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoMCM PEDIATRIC AND ADOLESCENT HOME PRACTICE, P.A.
ROCKINGHAM, NC 28379
ROCKINGHAM, NC 28379
33aNPI1205967460assigned 03/08/2007
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$10.11M
24GClaims487,842
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in North Carolina
Rank by total paid#5 of 20
Median peer was paid$4.16M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,652 | $1.05M | |
| 2019 | 32,582 | $1.21M | |
| 2020 | 28,982 | $1.17M | |
| 2021 | 62,865 | $1.46M | |
| 2022 | 111,829 | $1.86M | |
| 2023 | 111,459 | $1.76M | |
| 2024incomplete | 107,473 | $1.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 34,573 | 30,016 | $2.96M |
| 99199 | Unlisted special service, procedure or report | 14% | 243,520 | 147,531 | $1.45M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 20,475 | 17,998 | $1.17M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.3% | 5,830 | 5,324 | $540K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.2% | 6,170 | 5,714 | $528K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.2% | 12,628 | 11,380 | $523K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.1% | 6,052 | 5,528 | $511K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.9% | 5,947 | 5,252 | $496K |
| 99401 | 3.6% | 13,405 | 11,127 | $368K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.5% | 7,668 | 6,178 | $355K |
| D0145 | Oral evaluation for a patient under three years of age | 1.4% | 4,149 | 3,816 | $141K |
| 99442 | 1.4% | 3,145 | 2,563 | $138K |
65 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 10,111 | $133K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.2% | 1,072 | $122K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 9,435 | $91K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,429 | $84K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,765 | $76K |
| D1206 | Topical application of fluoride varnish | <1% | 4,162 | $62K |
| 96127 | <1% | 15,625 | $61K | |
| 99070 | <1% | 9,351 | $56K | |
| 96160 | <1% | 6,978 | $23K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,005 | $22K |
| 99443 | <1% | 298 | $20K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 392 | $14K |
| 90651 | <1% | 1,335 | $14K | |
| 90461 | <1% | 6,393 | $13K | |
| 87807 | <1% | 990 | $13K | |
| 99381 | <1% | 132 | $13K | |
| 96161 | <1% | 3,139 | $10K | |
| 83655 | <1% | 676 | $9K | |
| 90620 | <1% | 916 | $9K | |
| 90734 | <1% | 1,110 | $9K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 270 | $8K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 360 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 220 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 441 | $7K |
| 95117 | <1% | 599 | $5K | |
| 99050 | <1% | 158 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 41 | $4K |
| 99441 | <1% | 158 | $4K | |
| 0071A | <1% | 74 | $4K | |
| 0072A | <1% | 61 | $3K | |
| 81003 | <1% | 1,032 | $3K | |
| Q3014 | Telehealth originating site facility fee | <1% | 115 | $2K |
| 90686 | <1% | 3,935 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 29 | $2K |
| 0073A | <1% | 28 | $2K | |
| 90474 | <1% | 105 | $1K | |
| 99173 | <1% | 12,250 | $1K | |
| 85018 | <1% | 951 | $1K | |
| 92551 | <1% | 6,138 | $1K | |
| 81025 | <1% | 183 | $1K | |
| 0002A | <1% | 14 | $845.00 | |
| 99051 | <1% | 20 | $556.00 | |
| 90688 | <1% | 29 | $294.30 | |
| 96380 | <1% | 12 | $188.54 | |
| 90715 | <1% | 162 | $161.47 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $152.70 |
| 36410 | <1% | 12 | $147.41 | |
| 90633 | <1% | 1,064 | $98.34 | |
| 99177 | <1% | 2,723 | $70.50 | |
| 82962 | <1% | 21 | $60.69 | |
| 90716 | <1% | 122 | $29.75 | |
| 90710 | <1% | 107 | $1.40 | |
| 90670 | <1% | 3,248 | $1.32 | |
| 90680 | 0% | 1,296 | $0.00 | |
| 90647 | 0% | 1,145 | $0.00 | |
| 90723 | 0% | 2,220 | $0.00 | |
| 90656 | 0% | 613 | $0.00 | |
| 90677 | 0% | 198 | $0.00 | |
| 91307 | 0% | 170 | $0.00 | |
| 90698 | 0% | 52 | $0.00 | |
| 90696 | 0% | 77 | $0.00 | |
| 90681 | 0% | 121 | $0.00 | |
| 91300 | 0% | 23 | $0.00 | |
| 90685 | 0% | 227 | $0.00 | |
| 90707 | 0% | 125 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMERGHANI, MOHAMED (MD)